New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2013
09:10 EDTSTEMStemCells launches Alzheimer's program, received first disbursement of $3.8M
StemCells announced that it has formally launched its Alzheimer's disease program, which is being supported by the California Institute for Regenerative Medicine, or CIRM. The goal of the project is to file, within four years, an Investigational New Drug, or IND, application with the FDA to evaluate the company's proprietary HuCNS-SC product candidate as a potential therapeutic in the treatment of Alzheimer's disease. CIRM has agreed to provide approximately $19.3M to the company in the form of a forgivable loan to help fund preclinical development and IND-enabling activities, and the company recently received an initial disbursement of $3.8M from CIRM. The funding was awarded under CIRM's Disease Team Therapy Development Award program in September 2012.
News For STEM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
10:04 EDTSTEMStemCells reports top line results for Phase I/II study in dry AMD
Subscribe for More Information
June 22, 2015
07:05 EDTSTEMStemCells data likely to be positive, says Cantor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use